DK0550157T3 - Antitumorpræparater og behandlingsmetoder - Google Patents
Antitumorpræparater og behandlingsmetoderInfo
- Publication number
- DK0550157T3 DK0550157T3 DK92311031.6T DK92311031T DK0550157T3 DK 0550157 T3 DK0550157 T3 DK 0550157T3 DK 92311031 T DK92311031 T DK 92311031T DK 0550157 T3 DK0550157 T3 DK 0550157T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydrogen
- halo
- compounds
- treatment
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/60—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/811,483 US5234955A (en) | 1991-12-20 | 1991-12-20 | Antitumor compositions and methods of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0550157T3 true DK0550157T3 (da) | 1997-12-01 |
Family
ID=25206668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92311031.6T DK0550157T3 (da) | 1991-12-20 | 1992-12-03 | Antitumorpræparater og behandlingsmetoder |
Country Status (9)
Country | Link |
---|---|
US (2) | US5234955A (da) |
EP (1) | EP0550157B1 (da) |
JP (1) | JPH05345755A (da) |
AT (1) | ATE155776T1 (da) |
CA (1) | CA2084469A1 (da) |
DE (1) | DE69221106T2 (da) |
DK (1) | DK0550157T3 (da) |
ES (1) | ES2104853T3 (da) |
GR (1) | GR3024986T3 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965132A (en) * | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
US6749853B1 (en) | 1992-03-05 | 2004-06-15 | Board Of Regents, The University Of Texas System | Combined methods and compositions for coagulation and tumor treatment |
EP0929540A4 (en) * | 1996-10-04 | 2001-12-12 | Lilly Co Eli | ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS |
TW486463B (en) * | 1997-10-04 | 2002-05-11 | Dev Center Biotechnology | Guanidine derivatives, method for making the same, and anti-cancer composition containing the same |
US6703020B1 (en) | 1999-04-28 | 2004-03-09 | Board Of Regents, The University Of Texas System | Antibody conjugate methods for selectively inhibiting VEGF |
EP1185559A2 (en) | 1999-04-28 | 2002-03-13 | Board Of Regents, The University Of Texas System | Compositions and methods for cancer treatment by selectively inhibiting vegf |
ATE337777T1 (de) * | 2001-06-15 | 2006-09-15 | Innovent Technology Ltd | Zusammensetzung zur behandlung von huf- und klauenerkrankungen |
WO2011009059A2 (en) * | 2009-07-17 | 2011-01-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Method of treating or preventing cancer |
US9341238B2 (en) | 2012-06-15 | 2016-05-17 | Gkn Driveline North America, Inc. | Power transfer unit straddle mount ring gear disconnect |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3083207A (en) * | 1963-03-26 | Indolinesulfonylureas | ||
DE1144259B (de) * | 1956-05-29 | 1963-02-28 | Hoechst Ag | Verfahren zur Herstellung von Sulfonylharnstoffen |
DE1159937B (de) * | 1960-06-29 | 1963-12-27 | Heyden Chem Fab | Verfahren zur Herstellung von Hydrindensulfonylharnstoffen |
US3097242A (en) * | 1960-06-29 | 1963-07-09 | Olin Mathieson | Hydrindene sulfonylureas |
US3102121A (en) * | 1961-06-29 | 1963-08-27 | Olin Mathieson | Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas |
DE1240866B (de) * | 1961-06-29 | 1967-05-24 | Heyden Chem Fab | Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen |
NL295122A (da) * | 1962-04-11 | |||
US3849110A (en) * | 1963-01-07 | 1974-11-19 | Lilly Co Eli | Herbicidal method employing aryl-sulfonylureas or salts thereof |
US3736122A (en) * | 1969-04-10 | 1973-05-29 | C Tung | Method of controlling plant growth |
AU1862083A (en) * | 1982-09-02 | 1984-03-08 | Duphar International Research B.V. | Tumor growth inhibitors |
CA1208561A (en) * | 1984-01-19 | 1986-07-29 | Marius S. Brouwer | Pharmaceutical compositions containing benzoylurea compounds |
US4845128A (en) * | 1984-06-27 | 1989-07-04 | Eli Lilly And Company | N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides |
GR862353B (en) * | 1985-09-23 | 1987-01-19 | Lilly Co Eli | Anti-tumor method and compounds |
CA1331464C (en) * | 1987-05-12 | 1994-08-16 | Eli Lilly And Company | Anti-tumor method and compounds |
-
1991
- 1991-12-20 US US07/811,483 patent/US5234955A/en not_active Expired - Fee Related
-
1992
- 1992-12-03 EP EP92311031A patent/EP0550157B1/en not_active Expired - Lifetime
- 1992-12-03 DK DK92311031.6T patent/DK0550157T3/da active
- 1992-12-03 DE DE69221106T patent/DE69221106T2/de not_active Expired - Fee Related
- 1992-12-03 CA CA002084469A patent/CA2084469A1/en not_active Abandoned
- 1992-12-03 AT AT92311031T patent/ATE155776T1/de active
- 1992-12-03 ES ES92311031T patent/ES2104853T3/es not_active Expired - Lifetime
- 1992-12-08 JP JP4327815A patent/JPH05345755A/ja active Pending
-
1993
- 1993-03-26 US US08/037,954 patent/US5354778A/en not_active Expired - Fee Related
-
1997
- 1997-10-09 GR GR970402629T patent/GR3024986T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69221106T2 (de) | 1997-12-11 |
EP0550157A1 (en) | 1993-07-07 |
DE69221106D1 (de) | 1997-08-28 |
EP0550157B1 (en) | 1997-07-23 |
US5354778A (en) | 1994-10-11 |
ES2104853T3 (es) | 1997-10-16 |
JPH05345755A (ja) | 1993-12-27 |
CA2084469A1 (en) | 1993-06-21 |
ATE155776T1 (de) | 1997-08-15 |
GR3024986T3 (en) | 1998-01-30 |
US5234955A (en) | 1993-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69201948D1 (de) | Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b. | |
FI922481A0 (fi) | Heterocykliska derivat. | |
CY1107391T1 (el) | Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις | |
ES2181853T3 (es) | Tratamiento del tinnitus empleando agentes neuroprotectores. | |
DK0550157T3 (da) | Antitumorpræparater og behandlingsmetoder | |
DE69429591D1 (de) | Therapeutisch wirksame Verbindungen | |
DK213290D0 (da) | Treatment of cerebrovascular disorders | |
FI945975A0 (fi) | Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
DK0625516T3 (da) | Benzensulfonamidderivater til behandling af blæreustabilitet | |
DK0659427T3 (da) | 2-Phenyl-3-azoylbenzothiophener til forøgelse af thrombomodulinekspression | |
FI902632A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita | |
HUT63837A (en) | Process for producing dibenz/b,f//1,4/oxazepin-11(10oh)-ones as active ingredients eliminating multiple drug resistance | |
DK0578477T3 (da) | Behandling af inflammatorisk tarmsygdom | |
DK469687D0 (da) | Derivater af 4,5-dihydrooxazoler og fremgangsmaade til fremstilling af saadanne derivater. | |
DK0784973T3 (da) | Quinoxalinderivater til behandling af tinnitus | |
FR2692262B1 (fr) | Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
NO953557L (no) | Antitumorpreparater og fremgangsmåte for deres fremstilling | |
DE69413545D1 (de) | Thiazole mit antiviraler wirkung | |
DK460789A (da) | 2-aminoacetamidderivater | |
DK0622372T3 (da) | Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse | |
JO1648B1 (en) | Nitrogen compounds |